Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Other Non-Current Assets: 2014-2024

Historic Other Non-Current Assets for KalVista Pharmaceuticals (KALV) over the last 5 years, with Dec 2024 value amounting to $1.4 million.

  • KalVista Pharmaceuticals' Other Non-Current Assets was N/A to $1.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $567,000 for FY2024, which is N/A change from last year.
  • According to the latest figures from Q4 2024, KalVista Pharmaceuticals' Other Non-Current Assets is $1.4 million, which was up 108.31% from $662,000 recorded in Q4 2024.
  • Over the past 5 years, KalVista Pharmaceuticals' Other Non-Current Assets peaked at $1.4 million during Q4 2024, and registered a low of $106,000 during Q3 2023.
  • Its 2-year average for Other Non-Current Assets is $579,000, with a median of $567,000 in 2024.
  • Data for KalVista Pharmaceuticals' Other Non-Current Assets shows a peak YoY surged of 470.75% (in 2024) over the last 5 years.
  • Over the past 4 years, KalVista Pharmaceuticals' Other Non-Current Assets (Quarterly) stood at $178,000 in 2020, then increased by 4.62% to $181,000 in 2021, then reached $337,000 in 2023, then surged by 96.44% to $1.4 million in 2024.
  • Its last three reported values are $1.4 million in Q4 2024, $662,000 for Q4 2024, and $605,000 during Q3 2024.